What Inspire Medical Systems Does & How It Makes Money (INSP)

Updated October 2026 · reflects Inspire Medical Systems's latest reported financials

Medical device maker of an implantable nerve stimulator for sleep apnea. The company makes money by selling its Inspire neurostimulation system, which surgeons implant in patients with moderate to severe OSA, in the United States and international markets.

How Inspire Medical Systems makes money

The company makes money by selling its Inspire neurostimulation system, which surgeons implant in patients with moderate to severe OSA, in the United States and international markets.

What Inspire Medical Systems does

Inspire Medical Systems is a medical technology company focused on obstructive sleep apnea (OSA), a common disorder in which the upper airway repeatedly collapses during sleep. Its core offering, the Inspire system, is an implanted neurostimulation therapy for patients with moderate to severe OSA, sold in the United States and internationally. The system is a closed-loop solution: it continuously monitors the patient's breathing and delivers mild stimulation to the hypoglossal nerve to keep the airway open. This makes it a minimally invasive alternative for OSA treatment. Founded in 2007, the company is headquartered in Golden Valley, Minnesota.

Products & services

• Inspire system
• Hypoglossal nerve stimulation therapy
• Closed-loop breathing-monitoring neurostimulation solution

What is Inspire Medical Systems worth?

On an owner-earnings DCF, Inspire Medical Systems's most-likely value is about $141 versus a recent price near $69 (105% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$49) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.

Related companies

ResMed (RMD) · LivaNova (LIVN) · Enovis (ENOV) · Medtronic (MDT) · AdaptHealth (AHCO)